ANZMTG - Australia and New Zealand Melanoma Trials Group Home | Login
ANZMTG - Australia and New Zealand Melanoma Trials Group
 

LOGIN



Please enter your username and password.


Username

Password


  
ANZMTG
 

ANZMTG 02.17 Can patient-led surveillance detect more early stage recurrent or new primary melanoma than clinician-led surveillance?

Study status - In Development
ANZ Clinical Trials Registry # - In Progress
ClinicalTrials.gov identifier - In Progress
 

Principal Investigator's details:
Dr Katy Bell
Email: 

ANZMTG coordinator details:

Email: anzmtg@melanoma.org.au
 
Documents (PDF downloads):
  • Trial Synopsis
  • Trial Protocol
  • Case Report Forms
  • Case Report Forms Completion Guidelines
  • Operations Manual
  • Trial Publications and Presentations
  • Site Contact


Return to Previous Page